DK3229840T5 - 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne - Google Patents

3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne Download PDF

Info

Publication number
DK3229840T5
DK3229840T5 DK15816887.2T DK15816887T DK3229840T5 DK 3229840 T5 DK3229840 T5 DK 3229840T5 DK 15816887 T DK15816887 T DK 15816887T DK 3229840 T5 DK3229840 T5 DK 3229840T5
Authority
DK
Denmark
Prior art keywords
stilben
acne
dihydroxy
isopropyl trans
topic treatment
Prior art date
Application number
DK15816887.2T
Other languages
Danish (da)
English (en)
Other versions
DK3229840T3 (da
Inventor
Javier Cote-Sierra
Susan H Smith
Steven M Frey
Original Assignee
Dermavant Sciences GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dermavant Sciences GmbH filed Critical Dermavant Sciences GmbH
Application granted granted Critical
Publication of DK3229840T3 publication Critical patent/DK3229840T3/da
Publication of DK3229840T5 publication Critical patent/DK3229840T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK15816887.2T 2014-12-12 2015-12-09 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne DK3229840T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201462090908P 2014-12-12 2014-12-12
PCT/IB2015/059490 WO2016092493A1 (en) 2014-12-12 2015-12-09 Novel method of use

Publications (2)

Publication Number Publication Date
DK3229840T3 DK3229840T3 (da) 2020-11-09
DK3229840T5 true DK3229840T5 (da) 2020-11-16

Family

ID=55025296

Family Applications (1)

Application Number Title Priority Date Filing Date
DK15816887.2T DK3229840T5 (da) 2014-12-12 2015-12-09 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne

Country Status (11)

Country Link
US (1) US10376475B2 (OSRAM)
EP (1) EP3229840B1 (OSRAM)
JP (3) JP7313117B2 (OSRAM)
KR (1) KR102607222B1 (OSRAM)
AR (1) AR102973A1 (OSRAM)
AU (1) AU2015358910B2 (OSRAM)
CA (1) CA2970739C (OSRAM)
DK (1) DK3229840T5 (OSRAM)
ES (1) ES2829637T3 (OSRAM)
TW (1) TWI692357B (OSRAM)
WO (1) WO2016092493A1 (OSRAM)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11617724B2 (en) 2015-05-21 2023-04-04 Dermavant Sciences GmbH Topical pharmaceutical compositions
SG11201708666RA (en) 2015-05-21 2017-12-28 Glaxosmithkline Ip Dev Ltd Topical pharmaceutical compositions
US20170231922A1 (en) * 2016-02-16 2017-08-17 Horizon GenoMed Therapeutics, Inc 3, 5-dihydroxy-4-isopropylstilbene (dhis) as miticidal agent and its therapeutic uses
IL274439B2 (en) 2017-11-10 2023-12-01 Dermavant Sciences GmbH Process for preparing tapinarof
US10967197B2 (en) 2018-08-29 2021-04-06 Azulite, Inc. Phototherapy devices and methods for treating truncal acne and scars
US11497718B2 (en) 2018-11-13 2022-11-15 Dermavant Sciences GmbH Use of tapinarof for the treatment of atopic dermatitis
US20220054467A1 (en) * 2019-02-25 2022-02-24 Sol-Gel Technologies Ltd. Treatment of psoriasis with topical tapinarof-tazarotene combination compositions
WO2020194313A1 (en) * 2019-03-26 2020-10-01 Sol-Gel Technologies Ltd. Treatment of hidradenitis suppurativa with tapinarof compositions
US20220287990A1 (en) * 2019-07-24 2022-09-15 Sol-Gel Technologies Ltd. Topical jak inhibitor combination compositions for treatment of inflammatory skin conditions
WO2021059281A1 (en) * 2019-09-26 2021-04-01 Sol-Gel Technologies Ltd. Treatment of skin disorders with topical combination compositions comprising tapinarof and an additional ahr activator
JP2023503132A (ja) * 2019-11-24 2023-01-26 ソル － ゲル テクノロジーズ リミテッド タピナロフおよびｐｄｅ４阻害剤を含む局所用組成物による皮膚障害の治療
CN116265421B (zh) * 2021-12-17 2024-01-02 上海泽德曼医药科技有限公司 用于预防或治疗中枢神经系统相关疾病的化合物
WO2023109859A1 (zh) * 2021-12-15 2023-06-22 上海泽德曼医药科技有限公司 二苯乙烯类化合物及其在用于预防和/或治疗中枢神经系统相关疾病中的应用
WO2024050431A2 (en) * 2022-08-30 2024-03-07 Dermavant Sciences GmbH Tapinarof and analogs thereof for use in treating ahr mediated diseases

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995003695A1 (en) 1993-07-27 1995-02-09 Agro-Biotech Corporation Novel fungicidal properties of metabolites, culture broth, stilbene derivatives and indole derivatives produced by the bacteria xenorhabdus and photorhabdus spp.
US5747482A (en) * 1996-07-30 1998-05-05 Bernstein; Lawrence R. Methods and compositions to inhibit keratinocyte proliferation
US20030171429A1 (en) 1999-12-06 2003-09-11 Genhui Chen Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxyltilbenes and novel stilbene derivatives and analogues
WO2004031117A1 (en) * 2000-10-06 2004-04-15 Welichem Biotech Inc. Novel bioactive diphenyl ethene compounds and their therapeutic applications
US7321050B2 (en) 1999-12-06 2008-01-22 Welichem Biotech Inc. Anti-inflammatory and psoriasis treatment and protein kinase inhibition by hydroxy stilbenes and novel stilbene derivatives and analogues
FR2917427B1 (fr) * 2007-06-18 2009-08-21 Galderma Res & Dev Inhibiteurs de tace dans le traitement de l'acne
US9308239B2 (en) * 2008-02-26 2016-04-12 The Penn State Research Foundation Methods and compositions for treatment of retinoid-responsive conditions
US20100003315A1 (en) * 2008-07-02 2010-01-07 Willeford Kenneth L Method and Composition for the Treatment of Skin Conditions
CN101531571B (zh) 2009-04-17 2013-03-20 河北科技大学 六次甲基四胺氧化合成二苯乙烯类化合物的方法
CN101633606B (zh) 2009-08-13 2014-08-27 河北科技大学 盐酸非均相氯代合成茋类化合物的方法
CN101648851B (zh) 2009-09-03 2012-10-10 河北科技大学 (e)-3,5-二羟基-4-异丙基二苯乙烯的清洁制备方法
CN101830764A (zh) 2010-05-05 2010-09-15 河北科技大学 利用Pfitzner-moffatt氧化反应合成茋类化合物的方法
CN101838173A (zh) 2010-05-07 2010-09-22 河北科技大学 利用Kornblum氧化反应合成茋类化合物的方法
EP2723889B1 (en) * 2011-06-27 2019-11-06 Galderma Research & Development New th17 differentiation markers for acne and uses thereof

Also Published As

Publication number Publication date
CA2970739C (en) 2023-10-03
CA2970739A1 (en) 2016-06-16
EP3229840A1 (en) 2017-10-18
AR102973A1 (es) 2017-04-05
EP3229840B1 (en) 2020-09-09
JP2021152018A (ja) 2021-09-30
AU2015358910B2 (en) 2019-01-24
US10376475B2 (en) 2019-08-13
JP2017537936A (ja) 2017-12-21
TWI692357B (zh) 2020-05-01
DK3229840T3 (da) 2020-11-09
JP2023123554A (ja) 2023-09-05
KR102607222B1 (ko) 2023-11-29
WO2016092493A1 (en) 2016-06-16
KR20170095928A (ko) 2017-08-23
TW201639548A (zh) 2016-11-16
AU2015358910A1 (en) 2017-06-29
JP7313117B2 (ja) 2023-07-24
ES2829637T3 (es) 2021-06-01
US20170360719A1 (en) 2017-12-21

Similar Documents

Publication Publication Date Title
IL283086A (en) Use of cannabidiol in the treatment of tuberous sclerosis complex
DK3229840T5 (da) 3,5-dihydroxy-4-isopropyl-trans-stilben til anvendelse i topisk behandling af akne
PL3139979T3 (pl) Jednostka, nebulizator i sposób
IL249981A0 (en) Method
EP3285633A4 (en) STEERING MICROENDOSCOPE
EP3218800C0 (en) SECURE MULTI-PARTY CALCULATION ON SPREADSHEETS
DK3778595T3 (da) Pancreatitisbehandling
DK3233221T3 (da) Træningsindretning
DK3231444T3 (da) Ny behandling
DK3524255T3 (da) Sammensætning til behandling af acne
DK3233786T3 (da) Polymorfe og amorfe former af (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6- dioxocyclohexa-1,4-dienyl)butanamid
HUE050944T2 (hu) Kezelési eljárás tradipitant alkalmazásával
EP3215219C0 (en) SKIN TREATMENT SYSTEM
DK3236960T3 (da) Fluralaner til anvendelse i behandling af demodicose
DK3302519T3 (da) Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom
DK3164123T3 (da) Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier
DK3188599T3 (da) Medicinske behandlinger baseret på anamorelin
DK3265057T3 (da) Topisk formulering
DK3125874T3 (da) Et terapeutisk middel til anvendelse i behandlingen af infektioner
PL3250042T3 (pl) Kompozycja, sposób, zastosowanie i wyrób
EP3271434C0 (de) Niedertemperatur-plasmabehandlung
DK3237407T3 (da) 3,5-diaminopyrazolkinasehæmmere
HRP20190314T1 (hr) Set za špricu
TH1501007933A (th) สารประกอบของอะโซล ไซเลน, สารละลายในการทรีตเมนท์พื้นผิว, วิธีการในการ ทรีตเมนท์พื้นผิว, และการใช้ของมัน
TH1501007285A (th) อุปกรณ์บำบัดน้ำเสีย